Evidence map›Paper›PMID 37334009›Full record

ArticleNetwork neuroscience (Cambridge, Mass.)2023

Graph theoretical approach to brain remodeling in multiple sclerosis.

AmirHussein Abdolalizadeh, Mohammad Amin Dabbagh Ohadi, Amir Sasan Bayani Ershadi, Mohammad Hadi Aarabi

Open access · goldAbstract read
In one paragraph

Article in Network neuroscience (Cambridge, Mass.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

AmirHussein AbdolalizadehStudents' Scientific Research Program, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-0465-5680
Mohammad Amin Dabbagh OhadiStudents' Scientific Research Program, Tehran University of Medical Sciences, Tehran, Iran.
Amir Sasan Bayani ErshadiStudents' Scientific Research Program, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Hadi AarabiDepartment of Neuroscience, Padova Neuroscience Center, University of Padova, Padova, Italy.
Tehran University of Medical Sciences · IRUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) is a neuroinflammatory disorder damaging structural connectivity. Natural remodeling processes of the nervous system can, to some extent, restore the damage caused. However, there is a lack of biomarkers to evaluate remodeling in MS. Our objective is to evaluate graph theory metrics (especially modularity) as a biomarker of remodeling and cognition in MS. We recruited 60 relapsing-remitting MS and 26 healthy controls. Structural and diffusion MRI, plus cognitive and disability evaluations, were done. We calculated modularity and global efficiency from the tractography-derived connectivity matrices. Association of graph metrics with T2 lesion load, cognition, and disability was evaluated using general linear models adjusting for age, gender, and disease duration wherever applicable. We showed that MS subjects had higher modularity and lower global efficiency compared with controls. In the MS group, modularity was inversely associated with cognitive performance but positively associated with T2 lesion load. Our results indicate that modularity increase is due to the disruption of intermodular connections in MS because of the lesions, with no improvement or preserving of cognitive functions.

Indexed as

CognitionDiffusion MRIGraph theoryMultiple sclerosisRemodeling

Identifiers

PMID37334009
PMCPMC10270718
OpenAlexW4296377114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.